Actually, I have some more questions, because in fact, speaking of your research, there's a copy of an article here that you've co-authored with three members of Pfizer's staff. The connections are very important for this matter, and the questions have to do with your ability to testify here today.
I would like to ask you if you can tell us about the ethics committees with the CIHR and their concerns, raised with the standing committee on ethics and then with the governing council, about this appointment. Can you clarify for the record what concerns were raised, how they were raised, and what was done about them?